“The global Scanning Electron Microscopes Market is anticipated to surpass USD 2 billion by 2020”, says Visiongain

07 November 2019
Pharma

Visiongain has launched a new pharma report “Scanning Electron Microscopes Market Report 2020-2030” Prospects by Type (Scanning, Transmission), Application (Automobiles, Electronics & Semiconductors, Pharmaceuticals, Steel & other metals, Other applications) and Geography.

The global scanning electron microscopes market is projected to grow on account increasing demand of nanotechnology-based research, growing applications in semi-conductor, electronics & pharmaceutical industries among other contributing growth factors. The global market is projected to grow at a lucrative CAGR of ~10% over the forecast period 2020-2030 and anticipated to surpass USD 2 billion by 2020.

The scanning electron microscope (SEM) remains one of the most powerful and versatile tools used in research, development and production environments. The SEM is capable of imaging a wide range of sample types & sizes, often with nominal sample preparation, and is capable of generating multiple analytical signals, thus providing high-resolution information about a sample's composition, phase, electrical, optical, and other properties.

Key market drivers include increasing demand for nanotechnology-based research and the consequent growth in investments and funding from regional government bodies. Also, increasing applications in the semiconductors, electronic and pharmaceutical industries is expected to boost growth over the forecast period from 2020 to 2030.

Increasing global emphasis on R&D for applications such as neuroscience, material science, life science, nanotechnology, and semiconductor industry is anticipated to boost demand for adoption of advanced and automated microscopes such as analytical electron microscope, microscope scanning probe, and SEM. Such microscopes have image resolution as high as 0.1 nm, which is important for these manufacturing industries.

In terms of application, pharmaceutical dominated the global scanning electron microscope market in 2018 with over 35% of the global market share. Also, the growing burden of chronic diseases and other diseases in anticipated to boost further growth especially in the developing regions across the globe.

In the year 2018, Asia Pacific dominated the global scanning electron microscope market with over 35% of the global market share. The key factor that accounts for its significant share is rapid growth in applications such as semiconductors, pharmaceuticals, and nanotechnology among other applications.

North America is the second-largest market in terms of revenue owing to the presence of research and academic institutes and an increasing number of clinical studies across the United States. Research-based activities in the life sciences, biotechnology, and pharmaceutical industries are an important part of North American countries ' innovation system and this is anticipated to increase the regional demand for SEM over the forecast period.

Some of the major players operating in this industry are Angstrom Advanced Inc., Bruker Corporation, Carl Zeiss, Danish Micro Engineering (DME), FEI Company, Hirox Europe Ltd., Hitachi High Technologies Corporation, JEOL Ltd, Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding, Thermo Fisher Scientific., ADVANTEST, COXEM Co., Ltd., and GETec Microscopy GmbH among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever